C WorldWide Group’s Immunomedics Inc IMMU Stock Holding History

C WorldWide Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-480,000	Closed	-$17M	–	100
2020 Q2	$17M	Buy	480,000 +40,000	+9%	+$1.17M	0.2%	41
2020 Q1	$5.93M	Hold	440,000	–	–	0.08%	52
2019 Q4	$9.31M	Hold	440,000	–	–	0.11%	51
2019 Q3	$5.83M	Hold	440,000	–	–	0.07%	55
2019 Q2	$6.1M	Buy	+440,000	New	+$6.62M	0.08%	56

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

C WorldWide Group's IMMU Position: Q3 2020 in Review

C WorldWide Group sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 480,000 shares — an estimated $17M sold.

C WorldWide Group first reported a position in IMMU in Q2 2019 and held it in 5 quarters. The position peaked at $17M in Q2 2020. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

C WorldWide Group reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
C WorldWide Group sold 480,000 Immunomedics Inc shares in Q3 2020, an estimated $17M.
C WorldWide Group first reported a position in Immunomedics Inc in Q2 2019 and held it in 5 quarters.
C WorldWide Group's Immunomedics Inc position peaked at $17M in Q2 2020.
408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on C WorldWide Group's 13F filing for Q3 2020, filed 2 Nov 2020.